QNTM
Quantum BioPharma Ltd.
NASDAQ: QNTM · HEALTHCARE · BIOTECHNOLOGY
$5.73
+1.42% today
Updated 2026-04-30
Market cap
$31.77M
P/E ratio
—
P/S ratio
91.86x
EPS (TTM)
$-8.20
Dividend yield
—
52W range
$2 – $38
Volume
0.5M
Quantum BioPharma Ltd. (QNTM) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-346.90%
ROA
-67.60%
Debt/equity
0.30x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | — | $-32800.00 | — | — | — |
| 2016 | — | $-29628.00 | — | — | — |
| 2017 | $20630.00 | $-2.80M | 100.00% | -13,586.02% | -13,586.02% |
| 2018 | — | $-16.67M | — | — | — |
| 2019 | — | $-39.13M | — | — | — |
| 2020 | $0.00 | $-31.80M | — | — | — |
| 2021 | $0.00 | $-35.29M | — | — | — |
| 2022 | $0.00 | $-23.61M | — | — | — |
| 2023 | $0.00 | $-17.90M | — | — | — |
| 2024 | $0.00 | $-14.20M | — | — | — |
| 2025 | $0.00 | $-26.63M | — | — | — |